4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-009258
EVP, Research & CSO sold 7,900 shares at $71.16 ($562,161)
- EVP, Research & CSO acquired 7,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-02-09 | Option exercise | +7,900 | $1.53 | $12,087 | 41,100 | D |
| Virgin Herbert EVP, Research & CSO | 2021-02-09 | Sale | −7,900 | $71.16 | $562,161 | 33,200 | D |
| Derivatives | |||||||
| Virgin Herbert EVP, Research & CSO | 2021-02-09 | Option exercise · Stock Option (Right to Buy) | −7,900 | 372,255 | D | ||
| Open-market sales · 7,900 sh · avg $71.16 · $562,161 | |||||||
Loading xslF345X03/doc4.xml…